Illinois Oncology Research Association Community Clinical Oncology Program

描述(由申请人提供)：总部设在伊利诺伊州皮奥里亚的伊利诺伊州肿瘤研究协会社区临床肿瘤学计划(IORA CCOP)的长期目标基本保持不变，因为它继续在社区环境中工作，以加快预防、治疗、恢复和治愈癌症的干预措施的发展。具体地说，IORA CCOP旨在扩大伊利诺伊州中部和西部社区癌症临床试验的收益；通过参与和采用临床研究试验结果，刺激整个社区的高质量护理；促进科学上可行的社区癌症网络的持续发展，与NCI赞助的合作团体试验合作；通过教育卫生保健专业人员和公众癌症预防、早期发现、适当治疗和持续护理的重要性，以及尽可能让初级保健医生和其他专家参与癌症预防试验，促进癌症预防、控制和治疗；增加已知和新的癌症治疗方法的知识库；并鼓励少数群体和未得到充分服务的人群参与癌症临床试验和相关研究。IORA CCOP及其附属机构提供在18个县的集水区进行癌症临床试验的机会。该地区占地超过12,000平方英里，大部分是农村地区，但大多数患者很容易在一个小时的车程内到达IORA CCOP在16个社区的25个组成部分/附属机构之一。虽然有6个附属机构在皮奥里亚本身，但IORA CCOP医学肿瘤学家每周前往皮奥里亚以外的所有15个社区，所有社区都得到该区域附属辐射设施的支持。IORA CCOP直接使用来自北中央癌症治疗组(NCCTG)、东部合作肿瘤组(ECOG)、癌症和白血病B组(CALGB)、国家外科辅助乳肠计划(NSABP)和放射治疗肿瘤组(RTOG)的最先进的研究方案，并通过临床试验支持股(CTSU)与美国和加拿大的其他研究小组间接使用。IORA CCOP与这些团体建立了良好的工作关系。其集中的记录保存和质量控制系统、多年的临床试验经验、工作人员的专业知识、CCOP肿瘤学团队的奉献精神以及患者权益倡导者的积极参与，都有助于在社区环境中进行持续的高质量研究，并产生患者利益和书面结果。

DESCRIPTION (provided by applicant): The long-term objectives of the Illinois Oncology Research Association Community Clinical Oncology Program (IORA CCOP), based in Peoria, IL, remain essentially unchanged as it continues to work within a community setting to accelerate the development of interventions for preventing, treating, recovering from and curing cancer. Specifically, the IORA CCOP seeks to expand accrual to cancer clinical trials in the communities of central and western Illinois; stimulate quality care throughout the community through participation in and adoption of results from clinical research trials; promote the continued growth of a scientifically viable community cancer network to work with NCI sponsored cooperative group trials; promote cancer prevention, control, and treatment by educating health care professionals and the public on the importance of cancer prevention, early detection, proper treatment and continuing care and by involving primary care physicians and other specialists in cancer prevention trials whenever possible; add to the knowledge base of known and new cancer treatments; and encourage the involvement of minority and underserved populations in cancer clinical trials and associated research. The IORA CCOP and its affiliates offer access to cancer clinical trials in an 18-county catchment area. This area spans more than 12,000 square miles of mostly rural country, yet most patients are easily within a one hour drive of one of the IORA CCOP's 25 components/affiliates in 16 communities. Although 6 of the affiliates are in Peoria itself, the IORA CCOP medical oncologists travel to all 15 communities outside Peoria weekly and all communities are supported by the affiliated radiation facilities in the region. The IORA CCOP uses state-of-the-art research protocols directly from the North Central Cancer Treatment Group (NCCTG), Eastern Cooperative Oncology Group (ECOG), Cancer and Leukemia Group B (CALGB), National Surgical Adjuvant Breast and Bowel Project (NSABP), and Radiation Therapy Oncology Group (RTOG), and indirectly, through the Clinical Trials Support Unit (CTSU), with other research groups in the United States and Canada. The IORA CCOP enjoys excellent working relationships with these groups. Its centralized record keeping and quality control systems, its years of clinical trials experience, the expertise of its staff, the commitment of the CCOP oncology team, and the active involvement of the research patient advocates all lend themselves to continued quality research conducted in a community setting and resulting in patient benefit and documented results.